As the crypto market rallies toward utility and decentralization, three tokens are gaining attention for very different reasons. Qubetics (TICS) has surged into the spotlight with its streamlined approach to cross-border remittances and a final-stage presale that’s raising eyebrows across the industry. Meanwhile, EOS is facing another volatile slump, and Injective (INJ) is reacting to broader market downturns despite previous gains.
What sets Qubetics apart? It’s a real solution for real people. From global freelancers to SMEs managing international transactions, Qubetics’ speed, smart contract suite, and presale momentum make it a standout candidate for the best 100x crypto in 2025. Qubetics is rooted in utility, demand, and tokenomics that actually make sense.
Qubetics: Redefining Cross-Border Transactions With Real-World Utility
As the cryptocurrency market continues its search for scalable and practical solutions, one project stands out for solving real-world issues, Qubetics (TICS). Positioned as a remittance-ready blockchain solution, Qubetics is gaining momentum during its final presale phase. With only 10 million tokens left priced at $0.3370, and more than $18 million raised from over 27,700 holders, Qubetics isn’t just promising, it’s delivering. This utility-first project has been strategically built for businesses, professionals, and retail users who seek fast, secure, and low-fee global transactions.
Cross-border payments remain plagued by delays, high fees, and inefficiencies. Qubetics addresses these directly through a high-speed infrastructure capable of near-instant settlements. Its integration of QubeQode smart contract support also allows businesses to tailor transactions to legal or compliance-based frameworks. This design makes it a top contender for the best 100x crypto, especially for beginners and enterprises that require more than speculation.
The platform’s decentralized model further ensures transparent governance. With a reduced total supply of 1.36 billion tokens, cut from 4 billion and a community-first allocation of 38.55%, Qubetics has created an organic scarcity model. Each of these tokenomics choices aligns with long-term value growth, which analysts believe could catalyze a 20% price surge upon listing.
The crypto presale now stands at the last stage. As of now, over 515 million $TICS tokens have been sold, locking in investor confidence. With just 10 million tokens remaining before public launch and a fixed price of $0.3370, the upside for early investors is clear. A move to $1 would yield a 197% return, while price milestones of $5, $10, or even $15 could turn modest investments into life-changing portfolios. These factors cement Qubetics’ spot among the best 100x crypto projects to watch in 2025.
EOS Drops 14.75%: What’s Behind the Price Plunge?
As of today, EOS (EOS) is trading at $0.543284, reflecting a sharp 14.75% drop in the past 24 hours. This downturn raises questions about EOS’s stability in an increasingly competitive smart contract environment. While EOS was once hailed for its scalable infrastructure and low-fee transactions, it has struggled to maintain its market position amid newer, more adaptive projects.
Part of the decline can be attributed to waning developer interest and a lack of meaningful ecosystem growth in recent months. Many DeFi builders have shifted toward newer chains like Arbitrum, Solana, and yes—even Qubetics, which provides built-in developer tools via QubeQode. This technical stagnation has made it difficult for EOS to remain relevant among the best 100x crypto prospects.
Community governance issues also plague EOS. The blockchain’s transition from a centralized Block.one era to its now “community-run” model has left gaps in leadership and strategic direction. Without a clear roadmap, institutional and retail confidence continues to fade. Market sentiment remains low, and without an immediate revival, EOS may further drift from relevance.
EOS still holds historical significance in the blockchain narrative. However, unless it reinvents itself through new partnerships, developer incentives, or innovative updates, it’s unlikely to recapture its former glory. For those hunting the best 100x crypto, EOS appears to be a relic rather than a rocket.
Injective (INJ) Falls 7.08%: Can the DeFi Protocol Rebound?
Injective (INJ) is currently priced at $12.52, following a 24-hour dip of 7.08%. Known for its decentralized exchange infrastructure and Layer-1 speed, Injective has carved out a niche in the DeFi sector. However, recent price action suggests growing skepticism from short-term investors. For those assessing best 100x crypto contenders, Injective offers both promise and caution.
The recent decline could stem from broader market sell-offs or profit-taking after INJ’s significant rally earlier this year. Yet, the fundamentals remain strong. Injective’s architecture supports zero-gas trading and derivatives—features that could gain traction with institutional users. Still, despite these advantages, market confidence appears shaken in the face of increasing competition from projects like Qubetics that offer broader utility and integrated toolkits.
Another challenge for Injective is its reliance on trading volume to sustain token value. While it does offer unique selling points, such as cross-chain asset support and integration with Cosmos, its tokenomics lack the burn mechanisms or scarcity narratives now favored by speculative investors. Qubetics’ model, with its sharply reduced supply and final presale opportunity, currently appeals more to those looking for outsized gains.
Overall, Injective remains a solid project within its niche but may not offer the same explosive growth potential as newer utility-based projects. Those searching for the best 100x crypto with real-world value may find Qubetics better aligned with current market expectations.
Conclusion: Why Qubetics Leads the 100x Crypto Race
While EOS and Injective each offer unique contributions to the crypto space, it’s clear that Qubetics stands at the forefront of real-world blockchain innovation. With a focus on solving tangible issues like cross-border payments, combined with a strong presale performance and token scarcity model, $TICS is positioned for substantial growth.
In contrast, EOS suffers from declining relevance and lack of innovation, while Injective, though technically robust, faces market fatigue and stiff competition. Investors looking for the best 100x crypto this month would be wise to consider Qubetics not just for its upside, but for its utility and long-term vision.
For More Information:
Qubetics: https://qubetics.com/
Presale: https://buy.qubetics.com/
Telegram: https://t.me/qubetics/
Twitter: https://x.com/qubetics/
FAQs
1. What makes Qubetics one of the best 100x crypto projects?
Qubetics offers real-world solutions like cross-border payments, native smart contract tools, and fast transaction speeds—all backed by strong tokenomics.
2. How much has Qubetics raised so far in its presale?
Qubetics has raised over $18 million and sold more than 515 million tokens across 27,700+ holders.
3. What’s the listing price potential for $TICS tokens?
The presale ends at $0.3370, with a projected listing price of $0.40 and long-term growth potential up to $15, making it a top candidate for best 100x crypto.
4. Why is EOS losing value?
EOS has dropped nearly 15% in 24 hours due to lack of innovation, declining developer support, and unclear roadmap.
5. Is Injective still worth investing in?
Injective remains technically strong, but for short-term explosive gains, Qubetics offers more appeal and upside potential.
Disclaimer: This is a sponsored press release. CryptosNewss does not endorse or guarantee the content. Readers should verify facts and conduct independent research before making financial decisions.
